Cell-active dual specificity phosphatase inhibitors identified by high-content screening

被引:61
作者
Vogt, A
Cooley, KA
Brisson, M
Tarpley, MG
Wipf, P
Lazo, JS [1 ]
机构
[1] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA
来源
CHEMISTRY & BIOLOGY | 2003年 / 10卷 / 08期
关键词
D O I
10.1016/S1074-5521(03)00170-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of extracellular signal-regulated kinase (Erk) is tightly controlled by dual specificity phosphatases (DSPases), but few inhibitors of Erk dephosphorylation have been identified. Using a high-content, fluorescence-based cellular assay and the National Cancer Institute's 1990 agent Diversity Set, we identified ten compounds (0.5%) that significantly increased phospho-Erk cytonuclear differences in intact cells. Three of the ten positive compounds inhibited the mitogen-activated protein kinase phosphatase-3 (MKP3/PYST-1) in vitro without affecting VHR or PTP1B phosphatases. The most potent inhibitor of MKP-3 had an IC50 of <10 muM and inhibited MKP-3 in a novel, fluorescence-based multiparameter chemical complementation assay. These results suggest that the phospho-Erk nuclear accumulation assay may be a useful tool to discover DSPase inhibitors with biological activity.
引用
收藏
页码:733 / 742
页数:10
相关论文
共 31 条
[1]   Evolution of anticancer drug discovery and the role of cell-based screening [J].
Balis, FM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :78-79
[2]   Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry [J].
Brunet, A ;
Roux, D ;
Lenormand, P ;
Dowd, S ;
Keyse, S ;
Pouysségur, J .
EMBO JOURNAL, 1999, 18 (03) :664-674
[3]   Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma [J].
Denkert, C ;
Schmitt, WD ;
Berger, S ;
Reles, A ;
Pest, S ;
Siegert, A ;
Lichtenegger, W ;
Dietel, M ;
Hauptmann, S .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) :507-513
[4]   THE PURIFICATION AND CHARACTERIZATION OF A HUMAN DUAL-SPECIFIC PROTEIN-TYROSINE-PHOSPHATASE [J].
DENU, JM ;
ZHOU, GC ;
WU, L ;
ZHAO, R ;
YUVANIYAMA, JD ;
SAPER, MA ;
DIXON, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :3796-3803
[5]   Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α -: Development and use of a high capacity fluorescence cytometric system [J].
Ding, GJF ;
Fischer, PA ;
Boltz, RC ;
Schmidt, JA ;
Colaianne, JJ ;
Gough, A ;
Rubin, RA ;
Miller, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28897-28905
[6]  
Dowd S, 1998, J CELL SCI, V111, P3389
[7]   Cell-based assays for identification of novel double-strand break-inducing agents [J].
Dunstan, HM ;
Ludlow, C ;
Goehle, S ;
Cronk, M ;
Szankasi, P ;
Evans, DRH ;
Simon, JR ;
Lamb, JR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :88-94
[8]   CDC25 PHOSPHATASES AS POTENTIAL HUMAN ONCOGENES [J].
GALAKTIONOV, K ;
LEE, AK ;
ECKSTEIN, J ;
DRAETTA, G ;
MECKLER, J ;
LODA, M ;
BEACH, D .
SCIENCE, 1995, 269 (5230) :1575-1577
[9]  
GERAN RI, 1972, CANCER CHEMOTH REP, V3, P11
[10]   High-content screening: A new approach to easing key bottlenecks in the drug discovery process [J].
Giuliano, KA ;
DeBiasio, RL ;
Dunlay, RT ;
Gough, A ;
Volosky, JM ;
Zock, J ;
Pavlakis, GN ;
Taylor, DL .
JOURNAL OF BIOMOLECULAR SCREENING, 1997, 2 (04) :249-259